These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 9191058

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Loss of IkappaB alpha-mediated control over nuclear import and DNA binding enables oncogenic activation of c-Rel.
    Sachdev S, Hannink M.
    Mol Cell Biol; 1998 Sep; 18(9):5445-56. PubMed ID: 9710628
    [Abstract] [Full Text] [Related]

  • 3. PEST-dependent cytoplasmic retention of v-Rel by I(kappa)B-alpha: evidence that I(kappa)B-alpha regulates cellular localization of c-Rel and v-Rel by distinct mechanisms.
    Rottjakob EM, Sachdev S, Leanna CA, McKinsey TA, Hannink M.
    J Virol; 1996 May; 70(5):3176-88. PubMed ID: 8627798
    [Abstract] [Full Text] [Related]

  • 4. Avian I kappa B alpha is transcriptionally induced by c-Rel and v-Rel with different kinetics.
    Schatzle JD, Kralova J, Bose HR.
    J Virol; 1995 Sep; 69(9):5383-90. PubMed ID: 7636983
    [Abstract] [Full Text] [Related]

  • 5. Interaction of the v-Rel oncoprotein with NF-kappaB and IkappaB proteins: heterodimers of a transformation-defective v-Rel mutant and NF-2 are functional in vitro and in vivo.
    White DW, Pitoc GA, Gilmore TD.
    Mol Cell Biol; 1996 Mar; 16(3):1169-78. PubMed ID: 8622661
    [Abstract] [Full Text] [Related]

  • 6. The v-Rel oncoprotein blocks apoptosis and proteolysis of I kappa B-alpha in transformed chicken spleen cells.
    White DW, Roy A, Gilmore TD.
    Oncogene; 1995 Mar 02; 10(5):857-68. PubMed ID: 7898928
    [Abstract] [Full Text] [Related]

  • 7. Differential pp40I kappa B-beta inhibition of DNA binding by rel proteins.
    Diehl JA, McKinsey TA, Hannink M.
    Mol Cell Biol; 1993 Mar 02; 13(3):1769-78. PubMed ID: 8441412
    [Abstract] [Full Text] [Related]

  • 8. Mutations in the rel-homology domain alter the biochemical properties of v-rel and render it transformation defective in chicken embryo fibroblasts.
    Morrison LE, Boehmelt G, Enrietto PJ.
    Oncogene; 1992 Jun 02; 7(6):1137-47. PubMed ID: 1594245
    [Abstract] [Full Text] [Related]

  • 9. Bcl-2 and CrmA have different effects on transformation, apoptosis and the stability of I kappa B-alpha in chicken spleen cells transformed by temperature-sensitive v-Rel oncoproteins.
    White DW, Gilmore TD.
    Oncogene; 1996 Sep 05; 13(5):891-9. PubMed ID: 8806678
    [Abstract] [Full Text] [Related]

  • 10. Expression of v-rel in a replication competent virus: transformation and biochemical characterization.
    Morrison LE, Boehmelt G, Beug H, Enrietto PJ.
    Oncogene; 1991 Sep 05; 6(9):1657-66. PubMed ID: 1656369
    [Abstract] [Full Text] [Related]

  • 11. The v-rel oncogene promotes malignant T-cell leukemia/lymphoma in transgenic mice.
    Carrasco D, Rizzo CA, Dorfman K, Bravo R.
    EMBO J; 1996 Jul 15; 15(14):3640-50. PubMed ID: 8670867
    [Abstract] [Full Text] [Related]

  • 12. Synergistic stimulation of avian I kappa B alpha transcription by rel and fos/jun factors.
    Kralova J, Schatzle JD, Liss AS, Bargmann W, Bose HR.
    Oncogene; 1996 Jun 20; 12(12):2595-604. PubMed ID: 8700518
    [Abstract] [Full Text] [Related]

  • 13. The v-Rel oncoprotein increases expression from Sp1 site-containing promoters in chicken embryo fibroblasts.
    Sif S, Capobianco AJ, Gilmore TD.
    Oncogene; 1993 Sep 20; 8(9):2501-9. PubMed ID: 8361761
    [Abstract] [Full Text] [Related]

  • 14. A chicken c-Rel-estrogen receptor chimeric protein shows conditional nuclear localization, DNA binding, transformation and transcriptional activation.
    Zurovec M, Petrenko O, Roll R, Enrietto PJ.
    Oncogene; 1998 Jun 18; 16(24):3133-42. PubMed ID: 9671392
    [Abstract] [Full Text] [Related]

  • 15. The relocalization of v-Rel from the nucleus to the cytoplasm coincides with induction of expression of Ikba and nfkb1 and stabilization of I kappa B-alpha.
    Hrdlicková R, Nehyba J, Roy A, Humphries EH, Bose HR.
    J Virol; 1995 Jan 18; 69(1):403-13. PubMed ID: 7983736
    [Abstract] [Full Text] [Related]

  • 16. AP-1 factors play an important role in transformation induced by the v-rel oncogene.
    Kralova J, Liss AS, Bargmann W, Bose HR.
    Mol Cell Biol; 1998 May 18; 18(5):2997-3009. PubMed ID: 9566919
    [Abstract] [Full Text] [Related]

  • 17. Heterologous C-terminal sequences disrupt transcriptional activation and oncogenesis by p59v-rel.
    Diehl JA, Hannink M.
    J Virol; 1993 Dec 18; 67(12):7161-71. PubMed ID: 8230438
    [Abstract] [Full Text] [Related]

  • 18. Mutations in the DNA-binding and dimerization domains of v-Rel are responsible for altered kappa B DNA-binding complexes in transformed cells.
    Hrdlicková R, Nehyba J, Bose HR.
    J Virol; 1995 Jun 18; 69(6):3369-80. PubMed ID: 7745683
    [Abstract] [Full Text] [Related]

  • 19. Transformation of avian fibroblasts overexpressing the c-rel proto-oncogene and a variant of c-rel lacking 40 C-terminal amino acids.
    Kralova J, Schatzle JD, Bargmann W, Bose HR.
    J Virol; 1994 Apr 18; 68(4):2073-83. PubMed ID: 8138992
    [Abstract] [Full Text] [Related]

  • 20. The v-rel oncogene encodes a cell-specific transcriptional activator of certain promoters.
    Gélinas C, Temin HM.
    Oncogene; 1988 Oct 18; 3(4):349-55. PubMed ID: 2856247
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.